Wahajuddin Wahajuddin

Biography

Dr Wahajuddin joined the Institute of Cancer Therapeutics from India after serving as Principal Scientist and Associate Professor (AcSIR) at the Pharmaceutics & Pharmacokinetics Division, CSIR- Central Drug Research Institute Lucknow. In addition to being a registered pharmacist in India, he is a registered patent agent with the Indian patent office, New Delhi. He had previously worked (2013-14) as a visiting scientist at UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, NC, USA and as Humboldt Research Fellow at University of Cologne Hospital’s Centre for Pharmacology, Cologne, Germany (2018-19).

Dr. Wahajuddin has published more than 150 publications in highly reputed peer reviewed international journals, eight patents, nine book chapters and edited a book for Nova Science Publishers, New York, USA. He has also won many awards and accolades like the Young Scientist Award 2013-14 from the State Government of Uttar Pradesh India, the Shakuntala Amir Chand Prize 2019 for Young Scientist by the Indian Council of Medical Research (ICMR) Govt. of India, Young Pharmaceutical Analyst Award 2012 from the Indian Drug Manufacturer’s Association, DBT- Cutting-edge Research Enhancement & Scientific Training (DBT-CREST) Award 2011-12 from the Dept. of Biotech. Govt. of India, Junior Investigator Award 2017 from Safety Pharmacological Society USA and ISMAS Young Mass Spectroscopist Award 2013 from the Indian Society for Mass Spectrometry etc. He has been elected a member of the Global Young Academy under the aegis of German National Academy of Sciences, Leopoldina Halle, Germany, Indian National Young Academy of Sciences, National Academy of Sciences (India), National Academy of Medical Sciences (India) and was admitted as Fellow of Royal Society of Biology (UK), Royal Society of Chemistry (UK) and Higher Education Academy (UK). He is one of the co-leads of Science Diplomacy in South Asia, a working group of the Global Young Academy (2020-2021). He is editor/editorial board member of many reputed high-impact scientific journals like Current Pharmaceutical Design, Current Drug Delivery (Section Editor: Novel pharmaceutical strategies from nanotechniques for effective drug delivery), Recent Patents on Anti-Cancer Drug Discovery (Section Editor: Anti-infective Formulation), Frontiers in Nanotechnology (Review Editor for Biomedical Nanotechnology) and Pharmacognosy Magazine.

Awards